Waystar, a leader in healthcare payment software, has announced significant amendments to its credit facilities, aiming to reduce borrowing costs and enhance its financial flexibility.
The move follows the company’s initial public offering (IPO) in mid-2024, reflecting its focus on optimising financial performance.
The amended credit agreement involves a repricing of Waystar’s term loan, which now carries a reduced interest rate of adjusted SOFR +2.25%, compared to the previous rate of adjusted SOFR +2.75%. Additionally, the company has expanded its revolving credit facility to $400m, up from $342.5m, while lowering the facility’s interest rate to adjusted SOFR +1.75%, down from SOFR +2.25%.
Waystar expects these amendments to significantly reduce its borrowing costs and generate interest expense savings. T
Waystar serves a vast network of healthcare providers, including 16 of the 20 institutions on the U.S. News Best Hospitals Honor Roll. Its platform processes over five billion healthcare payment transactions annually, representing $1.2trn in claims and covering nearly half of all U.S. patients. By simplifying healthcare payments, Waystar helps providers prioritise patient care while optimising financial outcomes.
Keep up with all the latest FinTech news here.
Copyright © 2025 FinTech Global
